Free Trial

Avacta Group (LON:AVCT) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?

Avacta Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell below the 200‑day moving average: LON:AVCT traded as low as GBX 63 versus its 200‑day MA of GBX 64.69, last at GBX 65 and down about 3.8% on volume of 7,330,272.
  • Mixed financial metrics and negative earnings: market cap £284.46m with a quick ratio of 4.96, current ratio 0.79, an extremely high debt‑to‑equity of 14,168.75, and a negative P/E of -3.70.
  • Clinical‑stage biopharma with a tumor‑targeting platform: Avacta develops the pre|CISION platform that masks toxic warheads and targets the tumor‑specific protease FAP to broaden cancer therapeutic delivery.
  • Five stocks we like better than Avacta Group.

Shares of Avacta Group Plc (LON:AVCT - Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 64.69 and traded as low as GBX 63. Avacta Group shares last traded at GBX 65, with a volume of 7,330,272 shares trading hands.

Avacta Group Trading Down 3.8%

The company has a quick ratio of 4.96, a current ratio of 0.79 and a debt-to-equity ratio of 14,168.75. The firm's 50-day simple moving average is GBX 61.61 and its 200 day simple moving average is GBX 64.69. The stock has a market capitalization of £284.46 million, a P/E ratio of -3.70 and a beta of 1.12.

Avacta Group Company Profile

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avacta Group Right Now?

Before you consider Avacta Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.

While Avacta Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines